Putnam Investments’s Adaptive Biotechnologies ADPT Stock Holding History

Putnam Investments’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$390K	Sell	79,596 -113,897	-59%	-$520K	﹤0.01%	1014
2023 Q3	$1.05M	Sell	193,493 -1,695	-0.9%	-$11.2K	﹤0.01%	825
2023 Q2	$1.31M	Sell	195,188 -6,128	-3%	-$45.6K	﹤0.01%	817
2023 Q1	$1.78M	Sell	201,316 -8,520	-4%	-$75.1K	﹤0.01%	753
2022 Q4	$1.6M	Sell	209,836 -118	-0.1%	-$918	﹤0.01%	763
2022 Q3	$1.49M	Sell	209,954 -3,828	-2%	-$36K	﹤0.01%	793
2022 Q2	$1.73M	Buy	+213,782	New	+$1.88M	﹤0.01%	777
2019 Q3	–	Sell	-31,013	Closed	-$1.5M	–	886
2019 Q2	$1.5M	Buy	+31,013	New	+$1.37M	﹤0.01%	749

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Putnam Investments's ADPT Position: Q4 2023 in Review

Putnam Investments reduced its Adaptive Biotechnologies (ADPT) stake by 59% in Q4 2023, selling an estimated $520K and leaving 79,596 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #1014.

Putnam Investments first reported a position in ADPT in Q2 2019 and has held it in 8 quarters since. The position peaked at $1.78M in Q1 2023. 200 funds tracked by Wall St. Rank hold ADPT as of Q4 2023.

Putnam Investments held 79,596 shares of Adaptive Biotechnologies worth $390K as of Q4 2023.
Putnam Investments sold 113,897 Adaptive Biotechnologies shares in Q4 2023, an estimated $520K.
Adaptive Biotechnologies made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1014 holding.
Putnam Investments first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 8 quarters since.
Putnam Investments's Adaptive Biotechnologies position peaked at $1.78M in Q1 2023.
200 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.